Recombinant GFAP Monoclonal Antibody
Product Specifications
Background
This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms.
Abbreviation
GFAP
UniProt
P14136
Host
Rabbit
Reactivity
Human; Mouse; Rat
Immunogen
Recombinant Human GFAP protein
Target
ZGC; etID36982; wu:fb34h; wu:fk42c; ALXDRD; GFAP; cb345; etID36982.3; FLJ42474; FLJ45472; gfapl; Glial Fibrillary Acidic Protein; Intermediate Filament Protein; wu:fb34h11; wu:fk42c12; xx:af506734; zgc:110485; wu:fb34h11; ALXDRD; cb345; etID36982.3; FLJ42474; FLJ45472; GFAP; GFAP; gfapl; Glial fibrillary acidic protein; Intermediate filament protein; wu:fk42c12; xx:af506734; zgc:110485
Clonality
Monoclonal,Recombinant
Clone
10A10
Conjugation
Unconjugated
Applications
WB; IHC
Field of Research
Neuroscience; Signal Transduction; Tags & Cell Markers; Stem Cells
Purification
Protein A
Concentration
0.2 mg/mL
Dilution
IHC 1:200-1:1000; WB 1:1000-1:5000
Buffer
PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
Shipping Conditions
Ice bag
Storage Conditions
Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Calculated Molecular Weight
50 kDa
Observed Molecular Weight
50 kDa
Isotype
IgG, κ
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
035595-ML405 100 µL
FDFT1, CT (FDFT1, Squalene synthase, FPP:FPP farnesyltransferase, Farnesyl-diphosphate farnesyltransferase) (MaxLight 405) discontinued
Ask
View Details 